Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 74.27 +0.11%   SPY: 167.17 +0.14%
Quote Spy TZYM NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Tranzyme (TZYM)

@ 3:59 PM
Click the portfolio to add TZYM:
Close [X]
+ Add TZYM to Portfolio
  
  Last Trade: $0.60 0.00 (0.82%)
  Volume: 296,025 48% of avg daily volume
       
  Avg Volume: 617,178
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 0.58 - 0.61
  Open: 0.61
  Previous Close: 0.60
  52-wk Range: 0.40 - 5.16
  Market Cap: 16.4M
  P/E: -0.9
  Div Yield: $0.00 (0.00%)
Indexes
2011 IPOs (0.0%)
Biotechnology Stocks (+0.9%)
Spy TZYM

? Pro holders
? Member holders
? Items submitted
Additional TZYM resources



Customize Links
To see which Pros and tickerspy members own TZYM Sign up now
Latest TZYM Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Tranzyme Pharma Announces First Quarter 2013 Financial Results
TZYM  
Linked by GlobeNewswire - May 09, 04:43PM from (globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., May 9, 2013 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) ("Tranzyme"), a biopharmaceutical  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma to Report First Quarter 2013 Financial Results
TZYM  
Linked by GlobeNewswire - May 02, 05:43AM from (globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., May 2, 2013 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that the Company  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma Announces Fourth Quarter and Full-Year 2012 Financial Results
TZYM  
Linked by GlobeNewswire - March 28, 04:43PM from (globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., March 28, 2013 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a biopharmaceutical company  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma to Report Fourth Quarter and Full-Year 2012 Financial Results
TZYM  
Linked by GlobeNewswire - March 13, 06:13PM from (globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., March 13, 2013 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that the  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma Announces Exploration of Strategic Alternatives
TZYM  
Linked by GlobeNewswire - February 08, 05:13AM from (globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., Feb. 8, 2013 (GLOBE NEWSWIRE) -- Tranzyme, Inc. (Nasdaq:TZYM) announced today that its Board  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma Promotes David Moore to Chief Business Officer
TZYM  
Linked by GlobeNewswire - January 15, 05:13AM from (globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., Jan. 15, 2013 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that David  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma Announces Successful Completion of Drug Discovery Collaboration With Bristol-Myers Squibb
TZYM  
Linked by GlobeNewswire - January 04, 05:13AM from (globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., Jan. 4, 2013 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a biopharmaceutical company  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma's DIGEST Trial Stopped for Futility After Interim Analysis of the Phase 2b Results
TZYM  
Linked by GlobeNewswire - December 17, 08:13AM from (globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., Dec. 17, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced it is discontinuing  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma Announces Resignation of Chief Financial Officer
TZYM  
Linked by GlobeNewswire - December 05, 04:43PM from (globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Richard  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma to Speak at Piper Jaffray Healthcare Conference
TZYM  
Linked by GlobeNewswire - November 20, 05:13AM from (globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Vipin  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource